Skip to main content

Table 2 Distribution of social, health and clinical patient’s variables by age groups in stage II, III rectal cancer (n = 503)a

From: Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer

 

N

<  65 years

N = 203

n (%)

65–80 years

N = 235

n (%)

>  80 years

N = 64

n (%)

P valueb

Sociodemographic variables

Sex

502

    

 Male

 

128 (63.1)

169 (71.9)

41 (64.1)

0.12

 Female

 

75 (36.9)

66 (28.1)

23 (35.9)

0.35

Deprivation index

476

    

 Quartile 1 least deprived

 

28 (14.7)

41 (18.6)

12 (18.8)

0.66

 Quartile 2

 

68 (35.6)

72 (32.6)

16 (25.0)

0.80

 Quartile 3

 

57 (29.8)

71 (32.1)

24 (37.5)

 

 Quartile 4 most deprived

 

38 (19.9)

37 (16.7)

12 (18.8)

 

Level of education

408

    

 Illiterate or with no formal education

 

9 (5.3)

30 (15.9)

11 (22.4)

< 0.0005

 Primary

 

100 (58.8)

137 (72.5)

33 (67.3)

< 0.0005

 Secondary

 

34 (20.0)

8 (4.2)

1 (2.0)

 

 University

 

27 (15.9)

14 (7.4)

4 (8.2)

 

Living arrangements

403

    

 Living alone

 

11 (6.7)

30 (15.8)

9 (18.8)

0.01

 Living with others

 

154 (93.3)

160 (84.2)

39 (81.3)

0.005

Family history of cancer

464

    

 No

 

97 (51.9)

126 (58.3)

42 (68.9)

0.06

 Yes

 

90 (48.1)

90 (41.7)

19 (31.1)

0.02

Screening

478

    

 No

 

167 (87.0)

199 (88.8)

58 (93.5)

0.36

 Yes

 

25 (13.0)

25 (11.2)

4 (6.5)

0.18

Health behaviours and comorbidities

Smoking habits

498

    

 Never smoker

 

82 (40.4)

104 (44.8)

37 (58.7)

0.001

 Current smoker

 

49 (24.1)

30 (12.9)

3 (4.8)

0.37

 Ex-smoker

 

72 (35.5)

98 (42.2)

23 (36.5)

 

Alcohol

483

    

 No

 

175 (89.3)

198 (87.2)

56 (93.3)

0.39

 Yes

 

21 (10.7)

29 (12.8)

4 (6.7)

0.70

ASA class

490

    

 I-II

 

144 (73.1)

118 (51.5)

31 (48.4)

< 0.0005

 III

 

51 (25.9)

101 (44.1)

31 (48.4)

< 0.0005

 IV

 

2 (1.0)

10 (4.4)

2 (3.1)

 

Charlson Index

502

    

 0

 

134 (66.0)

118 (50.2)

25 (39.1)

< 0.0005

 1

 

43 (21.2)

60 (25.5)

18 (28.1)

< 0.0005

  ≥ 2

 

26 (12.8)

57 (24.3)

21 (32.8)

 

Tumour characteristics

Histological classification

467

    

 Adenocarcinoma

 

181 (96.8)

201 (92.6)

58 (92.1)

0.05

 Mucinous adenocarcinoma

 

5 (2.7)

16 (7.4)

4 (6.3)

0.05

 Signet-ring cell carcinoma

 

1 (0.5)

0 (0.0)

0 (0.0)

 

 Other types of carcinoma

 

0 (0.0)

0 (0.0)

1 (1.6)

 

Degree of differentiation

389

    

 Low grade

 

137 (86.7)

153 (86.0)

48 (90.6)

0.68

 High grade

 

21 (13.3)

25 (14.0)

5 (9.4)

0.62

Stage at diagnosis (pTNM or cTNM)

502

    

 II

 

61 (30.0)

76 (32.3)

27 (42.2)

0.19

 III

 

142 (70.0)

159 (67.7)

37 (57.8)

0.11

Intervention

Main intervention

502

    

 Elective

 

200 (98.5)

234 (99.6)

64 (100.0)

0.35

 Emergency

 

3 (1.5)

1 (0.4)

0 (0.0)

0.16

Curative resection

476

    

 R0

 

162 (84.4)

193 (85.4)

52 (89.7)

0.60

 R1/R2

 

30 (15.6)

33 (14.6)

6 (10.3)

0.37

Surgeon’s profile

476

    

 General

 

59 (30.3)

71 (32.3)

18 (29.5)

0.87

 Coloproctologist

 

136 (69.7)

149 (67.7)

43 (70.5)

0.92

Cancer committee

418

    

 No

 

52 (27.2)

74 (33.2)

19 (29.7)

0.42

 Yes

 

139 (72.8)

149 (66.8)

45 (70.3)

0.42

  1. aAge was missing in a case
  2. bPearson Chi-square test to generate upper P value and chi-square test for trends to generate lower P value